Scholarly Index
Henkjan J. Verkade
University Medical Center Groningen; 12,398 total citations; 521 total publications; best world rank #21
University Medical Center Groningen
12,398Total citations
521Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 142 | NL 9 | 98.97 |
| Drug Transport and Resistance Mechanisms | Lifetime | 379 | NL 25 | 98.23 |
| Neonatal Health and Biochemistry | Lifetime | 326 | NL 9 | 97.43 |
| Congenital Anomalies and Fetal Surgery | Lifetime | 719 | NL 18 | 95.35 |
| Liver Diseases and Immunity | Lifetime | 640 | NL 17 | 95.34 |
| Cystic Fibrosis Research Advances | Lifetime | 801 | NL 22 | 94.72 |
| Cholesterol and Lipid Metabolism | Lifetime | 868 | NL 29 | 93.37 |
| Intestinal Malrotation and Obstruction Disorders | Lifetime | 657 | NL 22 | 91.99 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 213 | NL 3 | 87.18 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 21 | NL 1 | 98.78 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 28 | NL 3 | 96.75 |
| Liver Diseases and Immunity | 2021-2025 | 124 | NL 5 | 95.42 |
| Congenital Anomalies and Fetal Surgery | 2021-2025 | 350 | NL 10 | 82.36 |
| Intestinal Malrotation and Obstruction Disorders | 2021-2025 | 232 | NL 17 | 78.24 |